Home > Journals > Minerva Cardioangiologica > Past Issues > Minerva Cardioangiologica 2015 August;63(4) > Minerva Cardioangiologica 2015 August;63(4):297-315

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe PROMO
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Cite this article as

 

REVIEWS   

Minerva Cardioangiologica 2015 August;63(4):297-315

Copyright © 2015 EDIZIONI MINERVA MEDICA

language: English

Novel bioresorbable scaffolds technologies: current status and future directions

Stanetic B. M. 1, Iqbal J. 2, Onuma Y. 3, Serruys P. W. 4

1 Department of Cardiology, University Hospital Clinical Centre Banja Luka, Banja Luka, Bosnia and Herzegovina; 2 Manchester Heart Centre, Manchester Royal Infirmary, Manchester, UK; 3 Department of Interventional Cardiology, Erasmus University Medical Centre, Thoraxcenter, Rotterdam, The Netherlands; 4 International Centre of Circulatory Health, Imperial College London, London, UK


PDF


Over the past century, coronary artery disease (CAD) has remained a leading cause of death worldwide, managed with enormous progress by medicine, from the development of advanced drugs to highly sophisticated revascularization modalities. Among them, as confirmed by recent studies, bioresorbable scaffolds (BRSs) have shown to have the potential to overtake conventional stents. This review presents their material composition and properties, those currently used in clinical evaluation, and their current limitations and potential improvements.

top of page